CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Abdominal Aortic Aneurysm (Aaa)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Thoratic Aortic Aneurysm (Taa)
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1 Overview
5.1.1 Market size and forecast
5.2 Infrarenal
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pararenal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1 Overview
6.1.1 Market size and forecast
6.2 Traditional
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Complex
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1 Overview
7.1.1 Market size and forecast
7.2 Percutaneous Evar
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Fenestrated Evar
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Aortic Stents & Taa Graft
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Indication
8.2.3 North America Market size and forecast, by Site
8.2.4 North America Market size and forecast, by Anatomy
8.2.5 North America Market size and forecast, by Product
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Indication
8.2.6.1.2 Market size and forecast, by Site
8.2.6.1.3 Market size and forecast, by Anatomy
8.2.6.1.4 Market size and forecast, by Product
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Indication
8.2.6.2.2 Market size and forecast, by Site
8.2.6.2.3 Market size and forecast, by Anatomy
8.2.6.2.4 Market size and forecast, by Product
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Indication
8.2.6.3.2 Market size and forecast, by Site
8.2.6.3.3 Market size and forecast, by Anatomy
8.2.6.3.4 Market size and forecast, by Product
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Indication
8.3.3 Europe Market size and forecast, by Site
8.3.4 Europe Market size and forecast, by Anatomy
8.3.5 Europe Market size and forecast, by Product
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Indication
8.3.6.1.2 Market size and forecast, by Site
8.3.6.1.3 Market size and forecast, by Anatomy
8.3.6.1.4 Market size and forecast, by Product
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Indication
8.3.6.2.2 Market size and forecast, by Site
8.3.6.2.3 Market size and forecast, by Anatomy
8.3.6.2.4 Market size and forecast, by Product
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Indication
8.3.6.3.2 Market size and forecast, by Site
8.3.6.3.3 Market size and forecast, by Anatomy
8.3.6.3.4 Market size and forecast, by Product
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Indication
8.3.6.4.2 Market size and forecast, by Site
8.3.6.4.3 Market size and forecast, by Anatomy
8.3.6.4.4 Market size and forecast, by Product
8.3.6.5 Rest of Europe
8.3.6.5.1 Market size and forecast, by Indication
8.3.6.5.2 Market size and forecast, by Site
8.3.6.5.3 Market size and forecast, by Anatomy
8.3.6.5.4 Market size and forecast, by Product
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Indication
8.4.3 Asia-Pacific Market size and forecast, by Site
8.4.4 Asia-Pacific Market size and forecast, by Anatomy
8.4.5 Asia-Pacific Market size and forecast, by Product
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Indication
8.4.6.1.2 Market size and forecast, by Site
8.4.6.1.3 Market size and forecast, by Anatomy
8.4.6.1.4 Market size and forecast, by Product
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Indication
8.4.6.2.2 Market size and forecast, by Site
8.4.6.2.3 Market size and forecast, by Anatomy
8.4.6.2.4 Market size and forecast, by Product
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Indication
8.4.6.3.2 Market size and forecast, by Site
8.4.6.3.3 Market size and forecast, by Anatomy
8.4.6.3.4 Market size and forecast, by Product
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Indication
8.4.6.4.2 Market size and forecast, by Site
8.4.6.4.3 Market size and forecast, by Anatomy
8.4.6.4.4 Market size and forecast, by Product
8.4.6.5 Rest Of Asia Pacific
8.4.6.5.1 Market size and forecast, by Indication
8.4.6.5.2 Market size and forecast, by Site
8.4.6.5.3 Market size and forecast, by Anatomy
8.4.6.5.4 Market size and forecast, by Product
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Indication
8.5.3 LAMEA Market size and forecast, by Site
8.5.4 LAMEA Market size and forecast, by Anatomy
8.5.5 LAMEA Market size and forecast, by Product
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Indication
8.5.6.1.2 Market size and forecast, by Site
8.5.6.1.3 Market size and forecast, by Anatomy
8.5.6.1.4 Market size and forecast, by Product
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Indication
8.5.6.2.2 Market size and forecast, by Site
8.5.6.2.3 Market size and forecast, by Anatomy
8.5.6.2.4 Market size and forecast, by Product
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Indication
8.5.6.3.2 Market size and forecast, by Site
8.5.6.3.3 Market size and forecast, by Anatomy
8.5.6.3.4 Market size and forecast, by Product
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Becton, Dickinson and Company
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cardinal Health Inc
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 cook medical
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Endologix Inc
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lombard Medical Inc
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Medtronic Plc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Koninklijke Philips N.V.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Terumo Medical Corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 W. L. Gore & Associates Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 2. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION , 2020-2030,($MILLION)
TABLE 3. ENDOVASCULAR ANEURYSM REPAIR MARKET ABDOMINAL AORTIC ANEURYSM (AAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR THORATIC AORTIC ANEURYSM (TAA), BY REGION , 2020-2030,($MILLION)
TABLE 5. ENDOVASCULAR ANEURYSM REPAIR MARKET THORATIC AORTIC ANEURYSM (TAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 7. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR INFRARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 8. ENDOVASCULAR ANEURYSM REPAIR MARKET INFRARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PARARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 10. ENDOVASCULAR ANEURYSM REPAIR MARKET PARARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 12. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR TRADITIONAL, BY REGION , 2020-2030,($MILLION)
TABLE 13. ENDOVASCULAR ANEURYSM REPAIR MARKET TRADITIONAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR COMPLEX, BY REGION , 2020-2030,($MILLION)
TABLE 15. ENDOVASCULAR ANEURYSM REPAIR MARKET COMPLEX BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 17. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PERCUTANEOUS EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 18. ENDOVASCULAR ANEURYSM REPAIR MARKET PERCUTANEOUS EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR FENESTRATED EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 20. ENDOVASCULAR ANEURYSM REPAIR MARKET FENESTRATED EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR AORTIC STENTS & TAA GRAFT, BY REGION , 2020-2030,($MILLION)
TABLE 22. ENDOVASCULAR ANEURYSM REPAIR MARKET AORTIC STENTS & TAA GRAFT BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 24. ENDOVASCULAR ANEURYSM REPAIR MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 29. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 30. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 32. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 33. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 34. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 35. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 36. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 37. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 38. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 39. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 40. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 41. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 42. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 43. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 44. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 45. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 46. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 47. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 48. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 49. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 50. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 51. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 52. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 53. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 54. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 55. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 56. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 57. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 58. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 59. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 60. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 61. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 62. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 63. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 64. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 65. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 66. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 67. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 68. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 69. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 70. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 71. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 72. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 73. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 74. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 75. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 76. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 77. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 78. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 79. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 80. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 81. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 82. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 83. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 84. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 85. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 86. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 87. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 88. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 89. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 90. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 91. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 92. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 93. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 94. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 95. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 96. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 97. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 98. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 99. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 100. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 101. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 102. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 103. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 104. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 105. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 106. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 107. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 108. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 109. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 110.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 111.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 112.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 113.ABBOTT LABORATORIES: NET SALES,
TABLE 114.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 118.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 119.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 120.CARDINAL HEALTH INC: COMPANY SNAPSHOT
TABLE 121.CARDINAL HEALTH INC: OPERATING SEGMENTS
TABLE 122.CARDINAL HEALTH INC: PRODUCT PORTFOLIO
TABLE 123.CARDINAL HEALTH INC: NET SALES,
TABLE 124.CARDINAL HEALTH INC: KEY STRATERGIES
TABLE 125.COOK MEDICAL: COMPANY SNAPSHOT
TABLE 126.COOK MEDICAL: OPERATING SEGMENTS
TABLE 127.COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 128.COOK MEDICAL: NET SALES,
TABLE 129.COOK MEDICAL: KEY STRATERGIES
TABLE 130.ENDOLOGIX INC: COMPANY SNAPSHOT
TABLE 131.ENDOLOGIX INC: OPERATING SEGMENTS
TABLE 132.ENDOLOGIX INC: PRODUCT PORTFOLIO
TABLE 133.ENDOLOGIX INC: NET SALES,
TABLE 134.ENDOLOGIX INC: KEY STRATERGIES
TABLE 135.LOMBARD MEDICAL INC: COMPANY SNAPSHOT
TABLE 136.LOMBARD MEDICAL INC: OPERATING SEGMENTS
TABLE 137.LOMBARD MEDICAL INC: PRODUCT PORTFOLIO
TABLE 138.LOMBARD MEDICAL INC: NET SALES,
TABLE 139.LOMBARD MEDICAL INC: KEY STRATERGIES
TABLE 140.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 141.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 142.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 143.MEDTRONIC PLC: NET SALES,
TABLE 144.MEDTRONIC PLC: KEY STRATERGIES
TABLE 145.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 146.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 147.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 148.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 149.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 150.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 151.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 152.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 153.TERUMO MEDICAL CORPORATION: NET SALES,
TABLE 154.TERUMO MEDICAL CORPORATION: KEY STRATERGIES
TABLE 155.W. L. GORE & ASSOCIATES INC: COMPANY SNAPSHOT
TABLE 156.W. L. GORE & ASSOCIATES INC: OPERATING SEGMENTS
TABLE 157.W. L. GORE & ASSOCIATES INC: PRODUCT PORTFOLIO
TABLE 158.W. L. GORE & ASSOCIATES INC: NET SALES,
TABLE 159.W. L. GORE & ASSOCIATES INC: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/